Inactivation of muscle insulin and IGF-I receptors and insulin responsiveness

Derek Le Roith1, Hyunsook Kim, Ana M Fernandez

  • 1Clinical Endocrinology Branch, National Institutes of Health, Bethesda, Maryland 20892-1758, USA. derek@helix.nih.gov

Abstract

Insights

Impaired insulin-stimulated skeletal muscle glucose uptake in mice leads to severe insulin resistance and type 2 diabetes. This highlights the critical role of muscle glucose transport in maintaining whole-body glucose homeostasis.

Area of Science:

  • Metabolic research
  • Endocrinology
  • Molecular biology

Background:

  • Insulin resistance is a key feature of type 2 diabetes, primarily affecting peripheral tissues like skeletal muscle.
  • Skeletal muscle glucose uptake is regulated by both the insulin receptor and insulin-like growth factor I receptor.

Purpose of the Study:

  • To review advances in understanding insulin-stimulated skeletal muscle glucose uptake.
  • To examine the impact on whole-body glucose homeostasis using mouse models.

Main Methods:

  • Utilized gene-deletion mouse models targeting muscle glucose transport protein 4.
  • Employed transgenic mouse models to abrogate insulin-like growth factor I receptor and insulin receptor function.

Main Results:

  • Gene deletion of muscle glucose transport protein 4 induced severe insulin resistance and hyperglycemia.
  • Abrogation of insulin-like growth factor I receptor and insulin receptor signaling led to severe insulin resistance and diabetes progression.
  • Common signaling pathways, glucotoxicity, and lipotoxicity are implicated in the development of type 2 diabetes.

Conclusions:

  • Disruption of insulin-stimulated glucose uptake in skeletal muscle can precipitate severe insulin resistance and diabetes in mouse models.
  • These findings underscore the importance of skeletal muscle's role in glucose metabolism and diabetes pathogenesis.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...